eEANO Webinars (SNO-EANO)
The European Association of Neuro-Oncology and the Society for Neuro-Oncology are pleased to announce the inaugural SNO-EANO webinar which will address the scientific highlights of the EANO and SNO conferences held in September and November of last year respectively.
Webinar on Highlights of SNO & EANO 2022 Annual Meetings, February 14, 2023 from 18:30-19:30hrs CET (12:30pm-1:30pm ET)
• Matthias Preusser - Medical University, Vienna, Austria
- ADC in HER2+ brain metastasis
• Linda Liau - University of California, Los Angeles, USA
- Autologous tumor lysate-loaded dendritic cell vaccination improves survival in patients with newly diagnosed and recurrent glioblastoma: survival results from a phase 3 trial
• Roel Verhaak - The Jackson Laboratory
- The longitudinal evolutionary trajectory of oligodendroglioma is driven by treatment-associated genetic alterations
• Pim J French - Erasmus University, The Netherlands
- Integrative molecular analysis of matched primary and recurrent IDH-mutant astrocytoma; an update from the GLASS-NL consortium
• Hideho Okada - University of California, San Francisco, USA
- Glioma-induced neuronal remodeling promotes regional immunosuppression
• Frank Winkler - University Hospital Heidelberg, Germany
- Disconnecting multicellular networks to tackle resistance in glioma
• Nancy Lin - Dana Farber Cancer Institute, Harvard Medical School, USA
• Roberta Ruda - University and City of Health and Science Hospital, Turin, Italy
SNO - EANO Leadership: • Priscilla Brastianos - Massachusetts General Hospital, Harvard Medical School, USA • Albert Kim - Washington University St. Louis School of Medicine, USA • Tracy Batchelor - Brigham and Women’s Hospital, USA • Susan Short - University of Leeds, UK • Michael Platten - Medical Faculty Mannheim, Heidelberg University, Germany • Manuel Valiente - Centro Nacional de Investigaciones Oncologicas, Spain
Please note all eEANO webinars will be submitted for CME accreditation, and are free of charge.
The eEANO webinars are accredited by the European Accreditation Council for Continuing Medical Education (EACCME®). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.